Articles by Daniel Marsh
AI Rally Faces Scrutiny as Wall Street Questions Profitability
U.S. stocks bounced back Monday after a chip-led $2 trillion rout, but investors are increasingly skeptical about AI spending delivering durable earnings amid rate hike fears.
Mortgage Rates Edge Lower, Yet Affordability Remains Elusive for Homebuyers
Mortgage rates eased to 6.48%, offering slight relief, but listing prices dropped 2.4% year-over-year to $429,500 amid persistent affordability challenges and rising geopolitical risks.
QQQ Rebounds 1.6% After Steep Drop; Options Signal Caution
QQQ bounces back 1.6% after a 4.8% selloff, with options data indicating trader caution rather than panic as Fed rate worries and AI spending concerns persist.
Tango Therapeutics Soars as Pancreatic Cancer Combo Shows 92% Response Rate
Tango Therapeutics shares rose sharply in premarket trading Monday after reporting a 92% objective response rate for its pancreatic cancer drug combo, with plans to move into Phase 3 testing.
Plug Power's Liquidity Focus Intensifies Ahead of CEO's June 11 Update
Plug Power shares rose 2.95% to $3.31 in pre-market trading Monday, recovering from a 10.69% drop on Friday, as investors await CEO Jose Luis Crespo's June 11 update on liquidity and asset sales.
SUNation Energy Skyrockets on Suniva Reverse Merger, Betting on U.S. Solar Manufacturing
SUNation Energy shares jumped 165% premarket on plans to merge with Suniva, shifting focus to domestic solar cell production. Pre-merger holders will own only 1.8% of the combined company.
ABAT Surges on Reinstated $115M DOE Lithium Grant
American Battery Technology (ABAT) shares surged over 29% premarket after the DOE reinstated a $115 million grant for its Nevada lithium refinery, fully restoring federal funding.
NANO Nuclear Rebounds as Market Eyes Insider Deals and Regulatory Milestone
NANO Nuclear Energy shares bounce 7.8% in premarket after a 9.9% Friday drop, with traders analyzing insider sales and regulatory progress on the KRONOS microreactor.
Nurix Surges on Roche's $2.3B Cancer Drug Pact
Nurix shares soared premarket after Roche committed up to $2.3 billion for bexobrutideg, with $700 million upfront, validating the BTK degrader ahead of Phase 3 trials.
SoFi Technologies Hovers Near $16 as Market Awaits Monday Open
SoFi Technologies stock hovers near $16 in pre-market trading, with markets watching Monday's open after a sharp drop last week, as investors assess record Q1 results against unchanged guidance.
